The pharmaceutical industry is expected to continue to grow in the coming years, driven by factors such as the aging population, the increasing prevalence of chronic diseases, and the development of new technologies. Moreover, given healthcare’s non-cyclical nature, the pharma industry is expected to stay stable, even under economic strains.
Amid this, let’s look into pharma stocks Novo Nordisk A/S (NVO), AbbVie Inc. (ABBV), and Novartis AG (NVS), which can boost your portfolio. But before we dive deeper into the stock fundamentals, let’s understand the industry landscape better.
